Verisign Inc. (VRSN) CEO discloses Dec 2025 insider stock sales filing
Rhea-AI Filing Summary
Verisign Inc. executive chairman, president and CEO D. James Bidzos reported multiple sales of Verisign common stock on December 9–11, 2025. The Form 4 lists several transactions coded as sales at weighted-average prices between $239.56 and $250.98 per share, with each price reflecting numerous trades within narrow ranges.
After these transactions, Bidzos directly beneficially owns 430,099.1378 shares of Verisign common stock. This amount includes 132.6549 dividend equivalent restricted stock units acquired on November 25, 2025 under the company’s Amended and Restated 2006 Equity Incentive Plan.
Positive
- None.
Negative
- None.
FAQ
What insider transaction did Verisign (VRSN) disclose in this Form 4?
The filing reports that D. James Bidzos, executive chairman, president and CEO of Verisign Inc., executed multiple sales of Verisign common stock on December 9–11, 2025 at weighted-average prices between $239.56 and $250.98 per share.
Who is the reporting person in the Verisign (VRSN) Form 4 and what is his role?
The reporting person is D. James Bidzos, who is identified as a Director and an Officer of Verisign, serving as Exec. Chairman, President & CEO.
On which dates did Verisigns CEO sell shares and how are the prices reported?
The Form 4 shows stock sales on December 9, 10 and 11, 2025. For each group of trades, the filing reports a weighted-average sale price, with detailed notes stating that the shares were sold in multiple transactions within price ranges from $239.56 up to $250.98 per share.
How many Verisign (VRSN) shares does the CEO own after the reported transactions?
Following the reported sales, D. James Bidzos beneficially owns 430,099.1378 shares of Verisign common stock directly. This figure includes 132.6549 dividend equivalent restricted stock units acquired on November 25, 2025 under Verisigns Amended and Restated 2006 Equity Incentive Plan.
Does this Verisign (VRSN) Form 4 report any derivative securities for the CEO?
The filing contains a Table II section for derivative securities, but it shows no listed derivative securities or transactions for the reporting person during the covered period.